Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AGEN-2373 by Agenus for Castration-Resistant Prostate Cancer (CRPC): Likelihood of Approval
AGEN-2373 is under clinical development by Agenus and currently in Phase I for Castration-Resistant Prostate Cancer (CRPC). According to GlobalData,...
Data Insights
AGEN-2373 by Agenus for Castration-Resistant Prostate Cancer (CRPC): Likelihood of Approval
AGEN-2373 is under clinical development by Agenus and currently in Phase I for Castration-Resistant Prostate Cancer (CRPC). According to GlobalData,...